Quantcast
Home / News Brief / Diabetes drug Actos linked to cancer risk

Diabetes drug Actos linked to cancer risk

The best-selling diabetes medicine may have raised the risk of bladder cancer in patients who took the drug for more than one year, according to the Food and Drug Administration.